Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Context: Vitamin B12 deficiency may occur with metformin treatment, but few studies have assessed risk with long-term use. Objective: To assess the risk of B12 deficiency with metformin use in the Diabetes Prevention Program (DPP)/DPP Outcomes Study (DPPOS). Design: Secondary analysis from the DPP/DPPOS. Participants were assigned to the placebo group (PLA) (n = 1082) or the metformin group (MET) (n = 1073) for 3.2 years; subjects in the metformin group received open-label metformin for an additional 9 years. Setting: Twenty-seven study centers in the United States. Patients: DPP eligibility criteria were: elevated fasting glucose, impaired glucose tolerance, and overweight/obesity. The analytic population comprised participants with available stored samples. B12 levels were assessed at 5 years (n = 857, n = 858) and 13 years (n = 756, n = 764) in PLA and MET, respectively. Interventions: Metformin 850 mg twice daily vs placebo (DPP), and open-label metformin in the metformin group (DPPOS). Main Outcome Measures: B12 deficiency, anemia, and peripheral neuropathy. Results: Low B12 (≤ 203 pg/mL) occurred more often in MET than PLA at 5 years (4.3 vs 2.3%; P = .02) but not at 13 years (7.4 vs 5.4%; P = .12). Combined low and borderline-low B12 (≤ 298 pg/mL) was more common in MET at 5 years (19.1 vs 9.5%; P < .01) and 13 years (20.3 vs 15.6%; P = .02). Years of metformin use were associated with increased risk of B12 deficiency (odds ratio, B12 deficiency/year metformin use, 1.13; 95% confidence interval, 1.06–1.20). Anemia prevalence was higher in MET, but did not differ by B12 status. Neuropathy prevalence was higher in MET with low B12 levels. Conclusions: Long-term use of metformin in DPPOS was associated with biochemical B12 deficiency and anemia. Routine testing of vitamin B12 levels in metformin-treated patients should be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vegetarian and vegan diets are associated with lower risk of DM, and, in persons with DM, these diets have been shown to lower glycemia and improve CVD risk factors.831,833,931,716–720,833,932”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [931]
In the citing paper
“Metformin use may result in lower serum vitamin B12 concentrations and worsening of symptoms of neuropathy; therefore, periodic monitoring and supplementation are generally recommended if levels are de fi cient, particularly in those with anemia or neuropathy (178,179).”
In the citing paper
“Metformin is associated with vitamin B12 de fi ciency, with a recentsystematicreview recommending that annual blood testing of vitamin B12 levels be considered in metformin-treated people, especially in those with anemia or peripheral neuropathy (257).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [257]
In the citing paper
“This study found that even in theabsenceofanemia,B12de fi ciencywas prevalent.”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [257]
In the citing paper
“Metformin use is also associated with increased risk of vitamin B12 deficiency and worsening of symptoms of neuropathy (102,103), suggesting periodic testing of vitamin B12 levels”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [103]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“The DPP and DPPOS design, eligibility, and baseline characteristics have been reported elsewhere (26, 27).”
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293 · cited 1×
“The Michigan Neuropathy Screening Instrument (MNSI) was conducted annually and was analyzed for DPPOS years 1 and 9, concurrent with B12 measurements (30).”
de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010) · BMJ · doi:10.1136/bmj.c2181 · Cited by 702 · cited 1×
“3 years, metformin reduced vitamin B12 concentration by 19%, increased homocysteine concentration by 5%, and was associated with an 11-fold increased risk in low vitamin B12 levels compared to placebo (19).”
Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin
Bauman, W. A., Shaw, S., Jayatilleke, E., Spungen, A. M., & Herbert, V (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1227 · Cited by 412
Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin
Ting, R. Z.-W. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.1975 · Cited by 333
Wile, D. J., & Toth, C. (2010) · Diabetes Care · doi:10.2337/dc09-0606 · Cited by 283 · cited 1×
“In a prospective case control study of diabetic patients referred for treatment of symptomatic peripheral neuropathy, metformin-treated patients had lower vitamin B12 levels and elevated methylmalonic acid and homocysteine levels, along with clinical and electrophysiological evidence of more severe peripheral neuropat…”
Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements
Reinstatler, L., Qi, Y. P., Williamson, R. S., Garn, J. V., & Oakley, G. P. (2012) · Diabetes Care · doi:10.2337/dc11-1582 · Cited by 265
Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Ogterop, J. C., Borger van der Burg, B., Donker, A. J. M., & Stehouwer, C. D. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01213.x · Cited by 244
Vitamin-B 12 Status of Patients on Long-term Metformin Therapy
Tomkin, G. H., Hadden, D. R., Weaver, J. A., & Montgomery, D. A. D. (1971) · BMJ · doi:10.1136/bmj.2.5763.685 · Cited by 225 · cited 1×
“As early as 1971, Tomkin et al (2) recommended that all patients on longterm metformin therapy have annual serum B12 testing, based on a cross-sectional evaluation.”
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Self-citation9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Metadata
- Authors
- Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., Crandall, J. P., & the Diabetes Prevention Program Research Group
- Affiliations
- MedStar Health Research Institute (US)
- George Washington University (US)
- University of Miami (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Washington (US)
- University of Pittsburgh (US)
- Pennington Biomedical Research Center (US)
- University of New Mexico (US)
- Washington University in St. Louis (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Crandall, Jill P.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-04-01
- Volume
- 101
- Issue
- 4
- Pages
- 1754-1761
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880159
- OpenAlex
- W2275928777
- Cited by
- 536
- References
- 42
- Citations by year
- 2026: 51 · 2025: 47 · 2024: 64 · 2023: 68 · 2022: 58 · 2021: 78 · 2020: 56 · 2019: 40 · 2018: 35 · 2017: 24 · 2016: 15
- FWCI
- 40.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR001409)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048375, U01DK048397, U01DK048406, U01DK048413, R01DK078907, U01DK048485, U01DK048400, U01DK048434, U01DK048380, U01DK048412, U01DK048411, U01DK048377, U01DK048437, U01DK048514, U01DK048489, U01DK048468, U01DK048407, U01DK048381, U01DK048443, U01DK048349, U01DK048387, U01DK048404, P30DK017047, P30DK020541)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, vitamin B12 deficiency, anemia, peripheral neuropathy, impaired glucose tolerance, type 2 diabetes prevention, Diabetes Prevention Program Outcomes Study, drug safety, impaired fasting glucose, overweight and obesity
- MeSH terms
- Adult, Aged, Anemia, Diabetes Mellitus, Type 2, Female, Homocysteine, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Vitamin B 12, Vitamin B 12 Deficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. https://app.cochat.ai/papers/10.1210/jc.2015-3754
- The paper
- Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., Crandall, J. P., & the Diabetes Prevention Program Research Group. (2016). Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2015-3754
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.